This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Oncology Nutrition Market

Oncology Nutrition Market By Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Pancreatic Cancer, Liver Cancer, Breast Cancer, Lung Cancer), End Use (Hospitals, Homecare, Specialty Clinics) & Region - Forecast 2022 - 2032

Market Insights on Oncology Nutrition covering sales outlook, demand forecast & up-to-date key trends

Oncology Nutrition Market Outlook (2022-2032)

[323 Pages Report] The oncology nutrition market is predicted to hit USD 2.21 billion by 2023, growing at an annual rate of 8.9% during the forecast period.

For the expansion of oncology-based nutrition formulas, factors such as the development of elemental formulae and product innovation in terms of non-GMO-based formulas provide considerable prospects.

Attributes

Details

Oncology Nutrition Market CAGR (2022-2032)

8.9%

Oncology Nutrition Market (2027)

USD 3.14 billion

Oncology Nutrition Market Attraction

The market is growing due to the improving quality of clinical research on nutritional therapies.

What is the COVID-19 Impact on the Oncology Nutrition Market?

Due to the pandemic situation, demand for oncology nutrition has declined. Due to imposed restrictions, patients are unable to obtain cancer treatment in hospitals.

Despite the COVID-19 crisis, the oncology nutrition market is expected to increase to US$ 2.88 billion by 2026, with a CAGR of 8.9% during the research period. 

One of the sectors of the oncology nutrition market is examined in the study; head & neck cancer is expected to expand at a 7.8% CAGR to reach US$472.2 million by the end of the analysis period. 

After a detailed examination of the pandemic's commercial ramifications and the resulting economic crisis, the Stomach & Gastrointestinal segment's growth of the oncology nutrition market is revised to 10.9% CAGR. The oncology nutrition market is now dominated by this sector, which holds a 22.9% oncology nutrition market share.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Contributors to the Oncology Nutrition Market?

In the forecast period, the oncology nutrition market would benefit from an increase in research and development efforts as well as the introduction of innovative products for cancer patient nutrition.

In addition, the future growth rate of the oncology nutrition market will be accelerated by the development of elemental formulations and the emergence of new markets.

Various countries are facing major healthcare issues as the number of cancer patients continues to rise. Several healthcare specialists believe that an unhealthy diet and an inactive lifestyle are to blame for about 85% of cancer incidences worldwide.

Tube-feeling-related problems may stifle the oncology nutrition market's development rate. Furthermore, the oncology nutrition market's expansion would be hampered by low reimbursement associated with its use. During the projection period, the oncology nutrition market would be further challenged by a lack of knowledge.

What are the Key Trends in the Oncology Nutrition Market?

The rise in cancer prevalence is the primary factor driving the oncology nutrition market’s expansion. The growing healthcare spending is another key element impacting the growth rate of the oncology nutrition market.

Furthermore, advancements in elemental approaches, rising government financing, and rising public and commercial sector activities to raise awareness about cancer patient nutrition are all aspects that will drive the oncology nutrition market forward.

Obesity and food, on the other hand, are responsible for 35% and 30% of all cancer-related fatalities, respectively. Patients receiving cancer treatment might boost their stamina and strength by eating a lot of healthy meals. The demand for nutritious foods is increasing as a result of their ability to inhibit cancer cell proliferation.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent Oncology Nutrition Market

Oncology Nutrition Market:

Attributes

Oncology Nutrition Market

CAGR (2022 - 2032)

8.9%

Oncology Nutrition Market Value (2026)

US$ 2.88 billion

Growth Factor

The rising need for nutritional goods for home care.

Opportunity

The need to fulfil the nutritional requirements of cancer patients is escalating.

Key Trends

The transition from parenteral to enteral nutrition, expanding cancer incidence, and growing demand for nutritional requirements are all driving market expansion.

Interventional Oncology Market:

Attributes

Interventional Oncology Market

CAGR (2022 - 2032)

6.9%

Oncology Nutrition Market Value (2026)

US$ 2.9 billion

Growth Factor

The key factors driving the growth of the interventional oncology market are technological improvements and the increased prevalence of oncology.

Opportunity

The interventional oncology market has a lot of room for expansion for both established and new product companies.

Key Trends

In several emerging economies, such as China, India, Brazil, and Mexico, rapid economic development and rising healthcare spending are projected to enhance access to high-quality healthcare.

Nutritional Analysis Market:

Attributes

Nutritional Analysis Market

CAGR (2022 - 2032)

8.5%

Oncology Nutrition Market Value (2026)

US$ 7.9 billion

Growth Factor

Shifting consumer tastes, greater health awareness, the growing millennial population, and a growth in supplemental income among consumers are all driving the industry.

Opportunity

The market for nutritional analysis will benefit from the rising favourable attitude on sports nutrition.

Key Trends

The need for nutritional analysis is being driven by changing lifestyles and a high frequency of chronic illnesses.

Other variables that would favourably affect the oncology nutrition market's growth rate include a rise in demand for nutritional food from the homecare sector and a change in lifestyle.

In addition, an increase in the number of clinical studies, quick product development, and a greater focus on enteral nutrition is likely to cushion the oncology nutrition market's growth.

What is the Segmentation Outlook for the Oncology Nutrition Market?

The oncology nutrition market is expanding rapidly, owing to the growing popularity of homecare nutritional products. Companies are inventing a wide range of new methods in order to capitalise on the available potential. 

The oncology nutrition market's major end-users are hospitals, retail pharmacies, and internet pharmacies. Due to the ever-increasing number of cancer patients, hospitals now hold the bulk of the oncology nutrition market

Various prominent worldwide healthcare providers are currently building high-end cancer diagnosis and care facilities in order to assure prompt treatment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Regional Analysis of the Oncology Nutrition Market?

The oncology nutrition market in the United States is expected to be worth US$ 412.6 million. The country presently holds 35.62% of the worldwide oncology nutrition market share.

China, the world's second-biggest economy, is expected to reach an oncology nutrition market size of US$165 million by 2026, representing a CAGR of 10.6% over the study period.

Japan and Canada are two additional important geographic oncology nutrition markets, with forecasted growth rates of 7.4% and 7.1%, respectively, throughout the projected period.

Within Europe, Germany is expected to increase at an annual rate of 8.4%, while the rest of the European oncology nutrition market will reach US$182.4 million.

Demand for oncology nutrition is predicted to increase in the United States, fueled by rising spending on various cancer medicines. Oncology nutrition product manufacturers will benefit greatly from all of these developments.

Asia-Pacific (APAC) is expected to be the fastest- oncology nutrition market.

The United States, Canada, Japan, China, and Europe are expected to fuel the worldwide pancreatic segment in the oncology nutrition market at 7.2% CAGR.

By the end of the analysis period, these regional oncology nutrition markets, which had a combined market value of US$170 million in 2020, will have grown to US $276.3 million.

In this group of regional oncology nutrition markets, China is likely to continue to be one of the fastest expanding. The Asia-Pacific oncology nutrition market is expected to reach US$19.2 million, led by nations like Australia, India, and South Korea, while Latin America is likely to grow at a 7.6% CAGR during the research period.

What is the Competitive Landscape of the Oncology Nutrition Market?

New product launches and continuous technological innovations are the key strategies adopted by the major players in the oncology nutrition market.

Nestle bought Allergan in January 2020 to grow its medical nutrition business.

Smartfish AS partnered with B. Braun to introduce Remune, a medicinal nutrition product, in September 2019. During 2019 and 2020, B. Braun will launch Remune in over 20 countries, with other oncology nutrition markets in Europe, Asia, and South America to follow.

Introduce Ina, the intelligent nutrition helper, was introduced by CancerCare in collaboration with Savor Health in 2019. The Ina offers tailored, evidence-based nutrition counselling to help cancer patients eat well and keep fed during their treatment.

Key Players

  • FMC Corporation
  • Danone India
  • Abbott
  • Aceto
  • B. Braun Melsungen AG
  • Baxter
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Meiji Holdings Co., Ltd
  • Nestlé S.A.
  • BioSig Technologies, Inc.
  • Auris Health, Inc.

KEY SEGMENTS

By Cancer Type

  • Head & Neck Cancer
  • Stomach & Gastrointestinal Cancers
  • Blood Cancer
  • Breast Cancer
  • Lung Cancer
  • Other cancers

By End Use:

  • Hospitals
  • Home Care
  • Others

By Geography:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The oncology nutrition market is projected to grow at a CAGR of 8.9% during the forecast period.

During the projection period of oncology nutrition market, the hospital sector is predicted to increase at an annual rate of 8.5% during the forecast period.

The hospital is predicted to have the greatest oncology nutrition market share based on distribution channel. During the projection period, it is predicted to grow at an annual rate of 8.5%, reaching US$ 1.06 billion in 2026.

The head and neck segment of oncology nutrition market is predicted to increase at a 9.7% CAGR. This is attributable to an increase in malignancies of the head and neck all across the world.

The highest oncology nutrition market share is predicted to be in North America. It is estimated to reach US$ 1.01 billion in 2026, growing at an annualised rate of 8.6% over the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Oncology Nutrition Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Cancer Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Bn) Analysis By Cancer Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Cancer Type, 2022-2032

        5.3.1. Head & Neck

        5.3.2. Stomach & Gastrointestinal

        5.3.3. Pancreatic

        5.3.4. Breast

        5.3.5. Liver

        5.3.6. Other Cancer Types

    5.4. Y-o-Y Growth Trend Analysis By Cancer Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Cancer Type, 2022-2032

6. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By End-Use

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Bn) Analysis By End-Use, 2017-2021

    6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End-Use, 2022-2032

        6.3.1. Hospitals

        6.3.2. Home Care

        6.3.3. Other End-Uses

    6.4. Y-o-Y Growth Trend Analysis By End-Use, 2017-2021

    6.5. Absolute $ Opportunity Analysis By End-Use, 2022-2032

7. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Cancer Type

        8.2.3. By End-Use

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Cancer Type

        8.3.3. By End-Use

    8.4. Key Takeaways

9. Latin America Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Argentina

            9.2.1.4. Chile

            9.2.1.5. Peru

            9.2.1.6. Rest of Latin America

        9.2.2. By Cancer Type

        9.2.3. By End-Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Cancer Type

        9.3.3. By End-Use

    9.4. Key Takeaways

10. Europe Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. U.K.

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Cancer Type

        10.2.3. By End-Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Cancer Type

        10.3.3. By End-Use

    10.4. Key Takeaways

11. Asia Pacific Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Rest of Asia Pacific

        11.2.2. By Cancer Type

        11.2.3. By End-Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Cancer Type

        11.3.3. By End-Use

    11.4. Key Takeaways

12. MEA Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Turkey

            12.2.1.4. Rest of MEA

        12.2.2. By Cancer Type

        12.2.3. By End-Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Cancer Type

        12.3.3. By End-Use

    12.4. Key Takeaways

13. Key Countries Oncology Nutrition Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Cancer Type

            13.1.2.2. By End-Use

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Cancer Type

            13.2.2.2. By End-Use

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Cancer Type

            13.3.2.2. By End-Use

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Cancer Type

            13.4.2.2. By End-Use

    13.5. Argentina

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Cancer Type

            13.5.2.2. By End-Use

    13.6. Chile

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Cancer Type

            13.6.2.2. By End-Use

    13.7. Peru

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Cancer Type

            13.7.2.2. By End-Use

    13.8. Germany

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Cancer Type

            13.8.2.2. By End-Use

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Cancer Type

            13.9.2.2. By End-Use

    13.10. France

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Cancer Type

            13.10.2.2. By End-Use

    13.11. U.K.

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Cancer Type

            13.11.2.2. By End-Use

    13.12. Spain

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Cancer Type

            13.12.2.2. By End-Use

    13.13. Russia

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Cancer Type

            13.13.2.2. By End-Use

    13.14. BENELUX

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Cancer Type

            13.14.2.2. By End-Use

    13.15. China

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Cancer Type

            13.15.2.2. By End-Use

    13.16. Japan

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Cancer Type

            13.16.2.2. By End-Use

    13.17. South Korea

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Cancer Type

            13.17.2.2. By End-Use

    13.18. GCC Countries

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2021

            13.18.2.1. By Cancer Type

            13.18.2.2. By End-Use

    13.19. South Africa

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2021

            13.19.2.1. By Cancer Type

            13.19.2.2. By End-Use

    13.20. Turkey

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2021

            13.20.2.1. By Cancer Type

            13.20.2.2. By End-Use

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Cancer Type

        14.3.3. By End-Use

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Abbott Laboratories

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

                15.1.1.5.2. Product Strategy

                15.1.1.5.3. Channel Strategy

        15.1.2. B. Braun Melsungen AG

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

                15.1.2.5.2. Product Strategy

                15.1.2.5.3. Channel Strategy

        15.1.3. Baxter International Inc.

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

                15.1.3.5.2. Product Strategy

                15.1.3.5.3. Channel Strategy

        15.1.4. Fresenius Kabi AG

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

                15.1.4.5.2. Product Strategy

                15.1.4.5.3. Channel Strategy

        15.1.5. Hormel Foods Corporation

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

                15.1.5.5.2. Product Strategy

                15.1.5.5.3. Channel Strategy

        15.1.6. Mead Johnson & Company LLC

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

                15.1.6.5.2. Product Strategy

                15.1.6.5.3. Channel Strategy

        15.1.7. Nestle S.A.

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

                15.1.7.5.2. Product Strategy

                15.1.7.5.3. Channel Strategy

        15.1.8. Pfizer Inc.

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

                15.1.8.5.2. Product Strategy

                15.1.8.5.3. Channel Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Oncology Nutrition Value (US$ Bn) Forecast by Region, 2017-2032

Table 2: Global Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 3: Global Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 4: North America Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 5: North America Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 6: North America Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 7: Latin America Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 8: Latin America Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 9: Latin America Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 10: Europe Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 11: Europe Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 12: Europe Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 13: Asia Pacific Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 15: Asia Pacific Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 16: MEA Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 17: MEA Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 18: MEA Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 2: Global Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 3: Global Oncology Nutrition Value (US$ Bn) by Region, 2022-2032

Figure 4: Global Oncology Nutrition Value (US$ Bn) Analysis by Region, 2017-2032

Figure 5: Global Oncology Nutrition Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Oncology Nutrition Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 8: Global Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 9: Global Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 10: Global Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 11: Global Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 12: Global Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 13: Global Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 14: Global Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 15: Global Oncology Nutrition Attractiveness by Region, 2022-2032

Figure 16: North America Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 17: North America Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 18: North America Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 19: North America Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 20: North America Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 23: North America Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 24: North America Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 25: North America Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 26: North America Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 27: North America Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 28: North America Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 29: North America Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 30: North America Oncology Nutrition Attractiveness by Country, 2022-2032

Figure 31: Latin America Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 32: Latin America Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 33: Latin America Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 34: Latin America Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 35: Latin America Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 38: Latin America Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 39: Latin America Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 40: Latin America Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 41: Latin America Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 42: Latin America Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 43: Latin America Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 44: Latin America Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 45: Latin America Oncology Nutrition Attractiveness by Country, 2022-2032

Figure 46: Europe Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 47: Europe Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 48: Europe Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 49: Europe Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 50: Europe Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 53: Europe Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 54: Europe Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 55: Europe Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 56: Europe Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 57: Europe Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 58: Europe Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 59: Europe Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 60: Europe Oncology Nutrition Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 62: Asia Pacific Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 63: Asia Pacific Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 64: Asia Pacific Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 68: Asia Pacific Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 69: Asia Pacific Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 70: Asia Pacific Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 71: Asia Pacific Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 72: Asia Pacific Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 73: Asia Pacific Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 74: Asia Pacific Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 75: Asia Pacific Oncology Nutrition Attractiveness by Country, 2022-2032

Figure 76: MEA Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 77: MEA Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 78: MEA Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 79: MEA Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 80: MEA Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 83: MEA Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 84: MEA Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 85: MEA Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 86: MEA Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 87: MEA Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 88: MEA Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 89: MEA Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 90: MEA Oncology Nutrition Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Oncology Nutrition Market